Himma Investments
Loading account and display preferences…
Loading application
Himma Investments
Home
Portfolio
News
Earnings
Macro
Special Situations
Themes
Log in
Sign up
Home
Portfolio
News
Earnings
Macro
Special Situations
Themes
Loading market prices…
New York
FILTERS · MARKET-WIDE · SCORE ≥7
Sign in
to filter the news.
SYMBOL
Apply
COVERAGE
Market-wide
Portfolio + Watchlist
Portfolio
MIN SCORE
All
≥5
≥7
≥9
CATEGORIES
Guidance
0
Analyst
0
Regulatory
0
M&A
0
Macro
0
Capital
0
Other
0
Filings · routine
0
Insider
0
Himma Investments
Home
Portfolio
News
Earnings
Macro
Special Situations
Themes
Log in
Sign up
Home
Portfolio
News
Earnings
Macro
Special Situations
Themes
SPY 767.50
+1.7%
DIA 533.43
+3.2%
QQQ 690.19
+0.7%
GLD 372.80
+3.8%
BTC 80,717.00
+4.9%
USO 145.00
−8.3%
New York
NEWS
Checks for new events every 30s
WEDNESDAY, NOV 4
16:08
PCVX
Vaxcyte Reports Positive OPUS-1 Phase 3 Topline Data for VAX-31 in Third Quarter 2026
9
10:16
SUBCY
Subsea 7 - CADE Approves the Combination of Subsea7 and Saipem
10
08:30
NKLR
Terra Innovatum Achieves Key NRC Licensing Milestone, Delivers All 18 SOLO™ PSAR Chapters for Readin
7
08:26
SKYUSD
UK Probes £1.6 Billion Sky-ITV Deal Over Public Interest Concern
9
08:15
SEPN
Septerna Selects SEP-204 as Development Candidate for Graves' Disease and TED
8
The wire runs all day · you're seeing 5 of 50 available events
Continue with Google
One click · free · no card
07:35
NAMS
NewAmsterdam Pharma Receives European Commission Approval for Ubeslo and Evlarco
10
07:10
QURE
UniQure Announces Third Quarter 2026 Results and FDA Priority Review of AMT-130
9
22:14
NVDA
Nvidia Tells Data Center Clients to Trim China Business, FT Says
8
18:13
MMM
3M Commits Nearly $7.4 Billion to Settle PFAS-Related Claims
8
16:18
TRAX
First Tracks Biotherapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
9
16:15
AQST
Aquestive Therapeutics Reports Third Quarter 2026 Results and Anaphylm FDA Resubmission Acceptance
9
